TPG Ventures and AmerisourceBergen Corporation have completed their acquisition of OneOncology, a network of leading oncology practices. TPG has acquired a majority interest in OneOncology with AmerisourceBergen acquiring a minority interest. The partnership will provide additional resources to OneOncology, which will allow the company to grow its platform and invest behind clinical, operational, and technical capabilities to continue delivering comprehensive patient care. The affiliated practices, physicians, and management team of OneOncology will also retain a minority interest in the company. TPG is a global alternative asset management firm while AmerisourceBergen is a leading global pharmaceutical solutions organization.
Keywords: TPG Ventures, AmerisourceBergen Corporation, acquisition, OneOncology, oncology practices.
TPG Ventures and AmerisourceBergen Corporation have joined forces to acquire OneOncology. This partnership provides an opportunity for OneOncology to expand its operations through investments in clinical, operational and technical capabilities. With this acquisition by two major firms in the field of healthcare services and pharmaceuticals respectively, it's expected that there will be significant growth within the industry as well as improved access to quality healthcare for patients across different regions.